Literature DB >> 35482224

Risk of Harm from Use of Sodium-Glucose Co-Transporter-2 (SGLT-2) Inhibitors in Patients Pre or Post Bariatric Surgery.

Mitesh Sharma1,2, Rahul Nayar3, Yitka Graham4,5, Helen M Parretti6, Sally Abbott7, Abd Tahrani8, Alexander D Miras9, Brijesh Madhok10, Rishi Singhal11, Kamal Mahawar4,5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35482224     DOI： 10.1007/s11695-022-06044-6

Source DB:  PubMed          Journal:  Obes Surg        ISSN： 0960-8923            Impact factor:   3.479


× No keyword cloud information.
  1 in total

Review 1.  Euglycemic Diabetic Ketoacidosis With Sodium-Glucose Cotransporter-2 Inhibitor Use Post-Bariatric Surgery: A Brief Review of the Literature.

Authors:  Qasim Z Iqbal; Danil Mishiyev; Zeeshan Zia; Raffaele A Ruggiero; Ghulam Aftab
Journal:  Cureus       Date:  2020-10-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.